MEX Equity Snapshot

BMY Weekly Equity Report

Bristol-Myers Squibb Company

Latest Close 969.9 MXN 12 Jun 2026
1W Return -2.0% latest completed week
4W Return -0.2% short-term follow-through
12W Return -5.6% quarterly tape
Trend Breadth 44.2% 23 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
Company Brief

What the company does

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive …

Snapshot

What the weekly tape is saying

BMY closed the latest completed week at 969.9 MXN. The 4-week return is -0.2% and the 12-week return is -5.6%. Trend Signal is inactive, Market Dynamics is -0.95. Setup signature: Risk-first tape with a 38/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -2.7%
Volume 0.8x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 24 Persistence of active Trend Signal over the last year and current streak.
Momentum 45 Blend of 4-week and 12-week follow-through.
Dynamics 28 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 43 Relative leadership and short-term RS change.
Volume 33 Participation compared with the 13-week volume baseline.
Risk Control 56 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
997.3 MXN
Vs Trend Line
-2.7%
Fair Value
957.6 MXN
Vs Fair Value
1.3%
52W High
1,103 MXN
52W Low
788.0 MXN
Drawdown
-12.1%
Range Position
57.7%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -2.0%
4W -0.2%
12W -5.6%
26W 3.5%
52W 2.5%

Trend read

Active Streak
0 weeks
52W Active Weeks
23
52W Active Breadth
44.2%
Sector Scope
MX Healthcare
Sector Rank
62 of 78
Sector Percentile
20.8%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.95
4W MD Change
-57.0%
Relative Strength
-2.78
4W RS Change
14.3%
Expectation
Undecided
Probability
47.49%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
442
13W Average
555
52W Average
8.7K
Vs 13W
0.8x
Vs 52W
0.1x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
4.3%
52W Volatility
3.8%
Upside Weeks
24
Downside Weeks
27
Downside Breadth
51.9%
Avg Gain / Loss
3.5% / -2.9%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
MEX
Country
MX
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
MXN
Market Cap
2052.3B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 969.9 MXN -2.0% 997.3 MXN 957.6 MXN -0.95 -2.78 442 Off
5 Jun 2026 989.5 MXN -1.5% 994.9 MXN 958.5 MXN -0.94 1.61 281 Off
29 May 2026 1,005 MXN -0.2% 990.8 MXN 959.3 MXN -0.90 -0.64 61 On
22 May 2026 1,007 MXN 3.6% 985.6 MXN 960.2 MXN -0.72 -0.12 68 On
15 May 2026 971.9 MXN 0.4% 979.4 MXN 961.0 MXN -0.61 -3.24 764 On
8 May 2026 968.0 MXN -7.9% 973.8 MXN 962.2 MXN -0.35 -6.36 3.2K On
1 May 2026 1,051 MXN 3.0% 969.1 MXN 963.7 MXN -0.20 4.36 320 On
24 Apr 2026 1,020 MXN -2.5% 962.5 MXN 964.6 MXN 0.00 -0.85 275 On
17 Apr 2026 1,047 MXN 3.2% 955.4 MXN 965.7 MXN 0.11 0.67 1.1K On
10 Apr 2026 1,014 MXN -8.0% 948.4 MXN 966.9 MXN 0.24 -3.18 29 On
3 Apr 2026 1,103 MXN 8.3% 943.2 MXN 968.5 MXN 0.60 5.02 77 On
27 Mar 2026 1,018 MXN -0.9% 935.8 MXN 969.3 MXN 0.80 0.60 300 On
20 Mar 2026 1,027 MXN -2.5% 931.0 MXN 970.6 MXN 1.24 4.50 233 On
13 Mar 2026 1,053 MXN -2.3% 927.0 MXN 972.0 MXN 1.42 3.78 3.6K On